Stock Events

Stock Events

Keros Therapeutics (KROS) Q1 2025 Earnings

26FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.41

-1.32

-1.23

-1.14

Details

Expected EPS

-1.355842

Actual EPS

-1.14

Surprise EPS

0.22

Surprise Percent

+15.92%

Description

Keros Therapeutics (KROS) has reported earnings of -1.14 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.